Office-based treatment for opioid dependence: Reaching new patient populations
Office-based treatment for opioid dependence: Reaching new patient populations
复制标题
DOI:
10.1176/appi.ajp.158.8.1200
复制
发表时间:
2001-08-01
影响因子:
17.7
通讯作者:
Kosten, TR
中科院分区:
文献类型:
--
作者:
Fiellin, DA;Rosenheck, RA;Kosten, TR
Heroin addiction is a costly and personally destructive public health problem that is often portrayed in the nonprofessional media as a problem primarily facing the lower socioeconomic segment of the US population. Epidemiologic studies, however, show that opioid addiction affects 810,000 people each year, representing all segments of American society, as well as their families and communities, with annual costs estimated at $21 billion (1). The most effective treatment for this disorder is opioid maintenance with medications such as methadone or levo-alpha-acetyl methadol (2). In this treatment, legal, long-acting, medically managed medications replace illegal drugs and block both the painful withdrawal syndrome and craving as well as the subjective drug high that motivate continued use (3). This treatment, however, has been significantly restricted by limited public funding, local opposition to the establishment of new clinics, state licensing restrictions, and stringent federal regulations designed to prevent the medication from being diverted from its medical use and resold as a substance of abuse on the street. These regulations restrict the delivery of these medications to specialized methadone clinics that are often located in undesirable neighborhoods, are inconvenient to reach, and require almost daily attendance. For these reasons, only about 15% of the total heroin-dependent population participates in methadone or levo-alpha-acetyl methadol treatment, although studies clearly demonstrate that this therapy is more effective than drug-free outpatient care in promoting sustained abstinence (4–6). Although progress has been made in developing more cost-effective methods for outpatient detoxification, this approach has limited long-term usefulness because of frequent relapses after detoxification, even in well-motivated patients with good social supports (7–10).